327 related articles for article (PubMed ID: 22319038)
1. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
[TBL] [Abstract][Full Text] [Related]
2. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.
Costa-Barbosa FA; Balasubramanian R; Keefe KW; Shaw ND; Al-Tassan N; Plummer L; Dwyer AA; Buck CL; Choi JH; Seminara SB; Quinton R; Monies D; Meyer B; Hall JE; Pitteloud N; Crowley WF
J Clin Endocrinol Metab; 2013 May; 98(5):E943-53. PubMed ID: 23533228
[TBL] [Abstract][Full Text] [Related]
4. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin JP; Dodé C
Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
[TBL] [Abstract][Full Text] [Related]
5. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
6. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
8. Submicroscopic deletion involving the fibroblast growth factor receptor 1 gene in a patient with combined pituitary hormone deficiency.
Fukami M; Iso M; Sato N; Igarashi M; Seo M; Kazukawa I; Kinoshita E; Dateki S; Ogata T
Endocr J; 2013; 60(8):1013-20. PubMed ID: 23657145
[TBL] [Abstract][Full Text] [Related]
9. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
10. Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction.
McCabe MJ; Gaston-Massuet C; Tziaferi V; Gregory LC; Alatzoglou KS; Signore M; Puelles E; Gerrelli D; Farooqi IS; Raza J; Walker J; Kavanaugh SI; Tsai PS; Pitteloud N; Martinez-Barbera JP; Dattani MT
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1709-18. PubMed ID: 21832120
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
[TBL] [Abstract][Full Text] [Related]
12. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
[TBL] [Abstract][Full Text] [Related]
13. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
[TBL] [Abstract][Full Text] [Related]
14. PROKR2 mutations in autosomal recessive Kallmann syndrome.
Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
[TBL] [Abstract][Full Text] [Related]
15. Compound deficiencies in multiple fibroblast growth factor signalling components differentially impact the murine gonadotrophin-releasing hormone system.
Chung WC; Matthews TA; Tata BK; Tsai PS
J Neuroendocrinol; 2010 Aug; 22(8):944-50. PubMed ID: 20553372
[TBL] [Abstract][Full Text] [Related]
16. Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD).
McCabe MJ; Hu Y; Gregory LC; Gaston-Massuet C; Alatzoglou KS; Saldanha JW; Gualtieri A; Thankamony A; Hughes I; Townshend S; Martinez-Barbera JP; Bouloux PM; Dattani MT
Mol Cell Endocrinol; 2015 Dec; 417():63-72. PubMed ID: 26375424
[TBL] [Abstract][Full Text] [Related]
17. Novel Mutations in HESX1 and PROP1 Genes in Combined Pituitary Hormone Deficiency.
Avbelj Stefanija M; Kotnik P; Bratanič N; Žerjav Tanšek M; Bertok S; Bratina N; Battelino T; Trebušak Podkrajšek K
Horm Res Paediatr; 2015; 84(3):153-8. PubMed ID: 26111865
[TBL] [Abstract][Full Text] [Related]
18. Combined pituitary hormone deficiency with unique pituitary dysplasia and morning glory syndrome related to a heterozygous PROKR2 mutation.
Asakura Y; Muroya K; Hanakawa J; Sato T; Aida N; Narumi S; Hasegawa T; Adachi M
Clin Pediatr Endocrinol; 2015 Jan; 24(1):27-32. PubMed ID: 25678757
[TBL] [Abstract][Full Text] [Related]
19. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.
Rainbow LA; Rees SA; Shaikh MG; Shaw NJ; Cole T; Barrett TG; Kirk JM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):163-8. PubMed ID: 15670191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
